Editas Medicine share price logo

Editas Medicine

NASDAQ: EDIT

$2.67

-0.25

(-8.56%)

as on

Editas Medicine Stock Performance

as on September 24, 2026 at 6:59 am IST

  • Day's High

    $2.67
    $3.14

    17.60%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.66
    $4.54
    downward going graph

    37.83%

    Downside

    69.93%

    Upside

    downward going graph

Editas Medicine share price movements today

Previous Close
$2.92
Open
$3.13
Volume
5.3M
Day's Low - High
$2.67 - $3.14
52 Week Low - High
$1.66 - $4.54

Editas Medicine Historical Returns

1 Month Return
-2.67 %
3 Month Return
+ 4.29 %
1 Year Return
-13.35 %
3 Year Return
-62.8 %
5 Year Return
-95.03 %

Editas Medicine Stock Fundamentals & Key Indicators

Check Editas Medicine market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

-0.7478

Dividend Yield

0.00%

PE Ratio (TTM)

-3.9

Industry PE ratio

0.00

PEG Ratio

-0.023883650942440868

Return On Equity TTM

-196.63%

Editas Medicine Stock Valuation

Track how Editas Medicine P/E has moved over time to understand its valuation trends.

Editas Medicine in the last 5 years

  • Overview

  • Trends

Lowest (-9.33x)

December 31, 2021

Industry (0.00x)

December 31, 2025

Today (-1.14x)

December 31, 2025

Highest (-0.44x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.14x

Editas Medicine vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Editas Medicine with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$--95.03%-3.956.90%0.00%
Neutral$--57.56%-22.88-12.57%0.00%
StrongBuy$-180.48%29.7386.04%0.00%
Buy$82.2B25.83%19.284.86%0.46%

Stock Returns calculator for Editas Medicine Stock including INR - Dollar returns

The Editas Medicine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Editas Medicine investment value today

Current value as on today

₹85,413

Returns

-₹14,587

(-14.59%)

Returns from Editas Medicine Stock

-₹20,772 (-20.77%)

Dollar Impact

₹6,184 (+6.18%)

Analyst Recommendation on Editas Medicine Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Editas Medicine. Average target price of $6

Editas Medicine Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
0
30
4
3
7
24
2
11
Gross Profit
0
0
-1
-18
-21
-12
-12
24
2
11
Operating Income
-66
-71
-65
-46
-76
-51
-24
-14
-25
-18
EBITDA
-60
-66
-60
-32
-71
-49
-21
-5
-23
-19
Interest Expense
-
-
-
-
2
2
2
-6
1
1
Depreciation
1
1
1
1
1
1
0
0
0
0
Income Before Tax
-61
-67
-62
-45
-76
-53
-25
-5
-24
-18
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-61
-67
-62
-45
-76
-53
-25
-5
-24
-18
Net Profit Margin
-24.14%
-176.80%
-2521.31%
-58.84%
-470.91%
-352.24%
-162.16%
100.00%
82.94%
100.00%

Editas Medicine Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
13
31
20
90
25
19
78
32
40
Gross Profit
-69
-58
-76
-67
20
13
72
-166
40
Operating Income
-119
-113
-140
-134
-193
-225
-169
-251
-99
EBITDA
-116
-110
-138
-130
-187
-214
-147
-233
-148
Interest Expense
0
-
-
-
-
-
-
-
6
Depreciation
2
3
2
3
5
6
6
5
5
Income Before Tax
-120
-109
-133
-115
-192
-220
-153
-237
-160
Income Tax Expense
-1
-
-
-
-
-
-
-
-
Net Income
-120
-109
-133
-115
-192
-220
-153
-237
-160
Net Profit Margin
-505.76%
-183.85%
-371.96%
-74.13%
80.22%
67.85%
92.24%
-516.60%
100.00%

Editas Medicine Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-61
-67
-62
-45
-76
-53
-25
-5
-24
-18
Operating Cash Flow
-49
-57
-52
-50
-47
-50
-30
-36
-23
-29
Investing Cash Flow
-4
51
83
30
56
42
39
0
0
-29
Financing Cash Flow
0
0
-
55
-1
7
17
17
-
117
Change in Cash
-54
-4
31
35
7
0
25
-19
-22
58

Editas Medicine Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-120
-109
-133
-115
-192
-220
-153
-237
-160
Operating Cash Flow
-9
-45
-40
-179
-163
-177
-132
-210
-165
Investing Cash Flow
-183
-53
12
-140
-54
114
-3
162
138
Financing Cash Flow
154
86
131
224
282
1
118
56
40
Change in Cash
-38
-11
103
-96
63
-61
-17
7
13

Mutual Funds that own Editas Medicine Stock

Check out the Mutual Funds with significant holdings in Editas Medicine.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.666545%
4095282
TIAA-CREF Funds
1.796987%
2759814
VANGUARD HORIZON FUNDS
1.489436%
2287477
Fidelity Salem Street Trust
0.72075%
1106929
Fidelity Concord Street Trust
0.522274%
802110

Global Institutional Holdings in Editas Medicine

Funds
Holdings
Peter Kolchinsky
5.79%
Vanguard
4.66%
iShares
3.57%
VANGUARD INDEX FUNDS
2.67%
Michael Rockefeller
2.32%

Insights on Editas Medicine

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EDIT stock has moved up by 7.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.83M → 11.88M (in $), with an average increase of 76.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -24.98M → -18.23M (in $), with an average increase of 37.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 82.6% return, outperforming this stock by 145.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 605.4% return, outperforming this stock by 618.8%

About Editas Medicine

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
OrganisationEditas Medicine
Headquarters11 Hurley Street, Cambridge, MA, 02141, US
IndustryBiotechnology
CEOGilmore O'Neill
E-voting on sharesClick here to vote

FAQs

What is Editas Medicine share price today?

Editas Medicine share price today is $2.67 as on at the close of the market. Editas Medicine share today touched a day high of $3.14 and a low of $2.67.

What is the 52 week high and 52 week low for Editas Medicine share?

Editas Medicine share touched a 52 week high of $4.54 on and a 52 week low of $1.66 on . Editas Medicine stock price today i.e. is closed at $2.67,which is 41.15% down from its 52 week high and 60.84% up from its 52 week low.

How to invest in Editas Medicine Stock (EDIT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Editas Medicine on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Editas Medicine Shares that will get you 0.5618 shares as per Editas Medicine share price of $2.67 per share as on September 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Editas Medicine Stock (EDIT) from India?

Indian investors can start investing in Editas Medicine (EDIT) shares with as little as ₹95.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in Editas Medicine stock (as per the Rupee-Dollar exchange rate as on ). Based on Editas Medicine share’s latest price of $2.67 as on September 24, 2026 at 1:29 am IST, you will get 3.7453 shares of Editas Medicine. Learn more about fractional shares .

What are the returns that Editas Medicine has given to Indian investors in the last 5 years?

Editas Medicine stock has given -95.03% share price returns and 29.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?